RxDoctor Payments Data

Eli Meltzer

San Diego, CANPI 1780602300

Payments from drug & device makers

$153,358in general payments, 2019–2025

Across 156 payments — averaging $983.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optinose US, Inc.$31K
  • Regeneron Healthcare Solutions, Inc.$26K
  • Alk-abello, Inc$21K
  • Merck$14K
  • Regeneron$13K
  • Sanofi$10K
  • plus $40K from 15 others
$96,405in research payments, 2019–2025

Across 27 payments — averaging $3570.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bristol Myers Squibb$43K
  • E.r. Squibb & Sons, L.L.C.$29K
  • F. Hoffmann-la Roche AG$24K

What the payments were for

  • Consulting fees$77,91051%
  • Speaking & faculty fees$57,78238%
  • Travel & lodging$12,8708%
  • Food & beverage$4,7773%
  • Education$200%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →